A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
Please note that all translations are automatically generated. Click here for the English version.
1.6K Views
•
04:15 min
•
February 2nd, 2024
DOI :
February 2nd, 2024
•1Department of Immunology, School of Medicine, UConn Health, 2Center for Molecular Discovery, University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 4Department of Pathology, University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center, University of New Mexico
Rozdziały w tym wideo
0:00
Introduction
0:43
High‐Throughput Screening of Compounds Using Neutrophils Isolated from Human Blood in a 384‐Well Plate Format
3:14
Neutrophils Screening Assay Using Flow Cytometry
Powiązane Filmy
09:28
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
14.9K Views
15:28
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
7.7K Views
09:14
Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
15.9K Views
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
3.4K Views
13:59
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
1.9K Views
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
10.3K Views
08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
7.4K Views
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
9.0K Views
06:56
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
13.6K Views
01:36
Test oparty na fluorescencji z wykorzystaniem zmodyfikowanych limfocytów do badań przesiewowych związków immunomodulujących
72 Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone